PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Pustuła, M.* ; Czub, M.* ; Łabuzek, B.* ; Surmiak, E.* ; Tomala, M.* ; Twarda-Clapa, A.* ; Guzik, K.* ; Popowicz, G.M. ; Holak, T.A.*

NMR fragment-based screening for development of the CD44-binding small molecules.

Bioorg. Chem. 82, 284-289 (2019)
Postprint DOI PMC
Open Access Green
The cell-surface protein CD44, a primary receptor for hyaluronic acid (HA), is one of the most promising targets for cancer therapies. It is prominently involved in the process of tumor growth and metastasis. The possibility of modulating the CD44-HA interaction with a pharmacological inhibitor is therefore of great importance, yet until now there are only few small molecules reported to bind to CD44. Here, we describe the results of the NMR fragment-based screening conducted against CD44 by which we found eight new hit compounds that bind to the receptor with the affinity in milimolar range. The NMR-based characterization revealed that there are two possible binding modes for these compounds, and for some of them the binding is no longer possible in the presence of hyaluronic acid. This could provide an interesting starting point for the development of new high-affinity ligands targeting the CD44-HA axis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.926
1.210
1
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cd44 ; Hyaluronic Acid ; Small-molecular Inhibitors ; Fragment-based Screening; Cell-surface Receptor; Chemical-shift Perturbation; Bivatuzumab Mertansine; Colorectal-cancer; Cd44 Expression; Binding Domain; Breast-cancer; Adhesion; Carcinoma; Antibody
Sprache englisch
Veröffentlichungsjahr 2019
Prepublished im Jahr 2018
HGF-Berichtsjahr 2018
ISSN (print) / ISBN 0045-2068
e-ISSN 1090-2120
Zeitschrift Bioorganic chemistry
Quellenangaben Band: 82, Heft: , Seiten: 284-289 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort San Diego, Calif.
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Structural Biology (STB)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503000-001
DOI 10.1016/j.bioorg.2018.10.043
WOS ID WOS:000455479600031
Scopus ID 85055903678
PubMed ID 30396062
Erfassungsdatum 2018-11-07
[➜Korrektur melden]